PRVANasdaqServices-Health ServicesFiscal year ends December 31

Privia Health Group, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$22.44−0.08 (-0.36%)

Close on Oct 19, 2026

Market cap: $2.96B
P/E (TTM): 106.9
Dividend yield: –

Privia Health Group, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31
Revenue	633	604	541	580	521	480	461	438	422	415	441	417	413	386	364	343	336	314	275	252	226	214	214	207	183	213
Selling, General & Admin	48	50	36	47	44	39	41	38	36	38	36	34	33	31	33	37	38	41	43	38	180	17	19	12	11	13
Selling & Marketing	8.00	8.13	6.45	6.96	6.81	6.92	6.46	7.05	6.85	6.09	6.25	7.24	5.96	5.29	5.17	5.09	4.82	4.66	3.80	4.59	11	3.18	3.96	2.71	2.22	2.45
General & Administrative	40	41	29	40	38	32	34	31	29	32	30	27	27	26	28	32	33	36	39	34	169	14	15	9.79	8.42	11
Operating Expenses	621	596	530	566	518	475	456	432	417	414	439	412	406	380	362	347	341	325	295	264	419	206	210	199	177	206
Operating Income	12	7.42	11	14	3.34	5.22	5.25	5.81	5.10	0.82	1.42	5.54	6.98	6.71	2.25	-4.57	-5.25	-12	-19	-13	-193	7.91	4.16	8.54	6.18	6.50
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.20	0.20	0.30	0.30	0.30	0.40	0.50	0.50	0.50
Other Non-Operating Income	–	1.89	2.09	2.27	2.41	2.93	2.77	2.16	2.97	2.98	2.85	2.89	0.82	–	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	17	9.31	13	17	5.74	8.15	8.02	7.98	8.06	3.81	4.27	8.43	7.80	8.53	3.40	-4.29	-5.91	-12	-20	-13	-193	7.62	3.73	8.04	5.67	6.03
Income Tax Expense	7.02	5.60	2.79	6.87	2.46	2.10	2.66	4.00	3.42	0.75	1.94	2.49	1.44	2.13	-13	-4.85	5.47	6.31	-7.64	-2.21	-20	2.00	-0.05	-8.56	0.47	0.70
Net Income incl. Noncontrolling Interests	9.73	3.71	11	9.81	3.29	6.05	5.37	3.98	4.64	3.06	2.32	5.94	6.36	6.40	17	0.56	-11	-18	-12	-11	-173	5.62	3.78	17	5.20	5.33
Minority Interest in Earnings	0.69	0.65	1.43	2.95	0.60	1.83	0.97	0.44	1.18	0.07	-0.51	0.30	-0.91	-0.92	-0.93	-1.07	-0.91	-0.58	0.09	-1.78	-0.95	0.22	-0.09	-0.09	-0.09	-0.09
Net Income	9.05	3.06	9.15	6.86	2.69	4.22	4.40	3.54	3.47	2.98	2.84	5.64	7.27	7.32	18	1.62	-10	-18	-12	-9.12	-173	5.40	3.86	17	5.28	5.41
EPS (Basic)(per share)	0.07	0.02	0.07	0.06	0.02	0.03	0.04	0.03	0.03	0.03	0.02	0.05	0.06	0.06	0.16	0.01	-0.10	-0.16	-0.11	-0.09	-1.68	0.06	0.04	0.17	0.06	0.06
EPS (Diluted)(per share)	0.07	0.02	0.07	0.05	0.02	0.03	0.03	0.03	0.03	0.02	0.02	0.05	0.06	0.06	0.16	0.01	-0.10	-0.16	-0.11	-0.09	-1.68	0.06	0.04	0.17	0.06	0.06
Shares Outstanding (Basic, Weighted)(shares)	126	124	123	123	122	121	120	120	119	119	118	118	116	115	114	112	109	108	107	106	103	96	96	96	96	96
Shares Outstanding (Diluted, Weighted)(shares)	132	131	130	129	128	128	126	126	125	125	125	125	125	124	114	125	109	108	107	106	103	96	96	96	96	96
EBITDA	15	11	14	17	5.92	7.12	7.08	7.61	6.92	2.64	3.19	7.27	8.67	8.05	3.38	-3.42	-4.09	-10	-18	-12	-193	8.35	4.62	9.00	6.77	6.83
Net Interest Income	–	–	–	–	–	–	–	–	–	2.98	2.85	2.89	0.82	1.81	1.15	0.29	-0.66	-0.23	-0.19	-0.29	-0.30	-0.29	-0.44	-0.50	-0.51	-0.47

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 1.9%
Net margin: 1.2%
Return on equity, FY2025: 3.3%

Financial strength

Current ratio: 1.62
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 65.0%

Valuation

P/E ratio: 106.9
Price to sales: 1.25
Price to book: 3.78
Dividend yield: –